Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use
出版年份 2022 全文链接
标题
Assessing chemotherapy-induced peripheral neuropathy with patient reported outcome measures: a systematic review of measurement properties and considerations for future use
作者
关键词
-
出版物
QUALITY OF LIFE RESEARCH
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-05-21
DOI
10.1007/s11136-022-03154-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical assessment of chemotherapy-induced peripheral neuropathy: a discrete choice experiment of patient preferences
- (2021) Alice Yu et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy-Induced Peripheral Neurotoxicity in Cancer Survivors: Predictors of Long-Term Patient Outcomes
- (2021) Eva Battaglini et al. Journal of the National Comprehensive Cancer Network
- Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral Neurotoxicity
- (2021) Paola Alberti et al. NEUROLOGY
- Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale
- (2020) Karen Kaiser et al. World Journal of Gastrointestinal Oncology
- The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy
- (2020) Cindy S. Tofthagen et al. Current Oncology Reports
- Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer
- (2020) Masaaki Miyo et al. BMC CANCER
- Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group—Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy
- (2020) Hui Lin Cheng et al. Health and Quality of Life Outcomes
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
- (2020) Charles L. Loprinzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study
- (2020) Tahira Devji et al. BMJ-British Medical Journal
- Can Methods Developed for Interpreting Group-level Patient-reported Outcome Data be Applied to Individual Patient Management?
- (2019) Madeleine T. King et al. MEDICAL CARE
- Minimal clinically important difference of the EORTC QLQ-CIPN20 for worsening peripheral neuropathy in patients receiving neurotoxic chemotherapy
- (2019) Fiona Yeo et al. SUPPORTIVE CARE IN CANCER
- Optimising clinical screening for chemotherapy-induced peripheral neuropathy
- (2019) J.Matt McCrary et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer
- (2019) K. Kanda et al. BMC CANCER
- Concerns regarding use of patient-reported outcomes in biomarker studies of chemotherapy-induced peripheral neuropathy
- (2019) Daniel L. Hertz PHARMACOGENOMICS JOURNAL
- Overview and critical revision of clinical assessment tools in chemotherapy‐induced peripheral neurotoxicity
- (2019) Susanna B. Park et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Psychometric evaluation of the Arabic Version the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20)
- (2019) Loai Abu Sharour Applied Neuropsychology-Adult
- Longitudinal validation and comparison of the Chinese version of the European Organization for Research and Treatment of Cancer Quality of Life-Chemotherapy-Induced Peripheral Neuropathy Questionnaire (EORTC QLQ-CIPN20) and the Functional Assessment of Ca
- (2018) Hui Lin Cheng et al. Asia-Pacific Journal of Clinical Oncology
- Psychometric Testing of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy 20-Item Scale Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization and Alliance for Clinical Trials in Oncology A151408 Study Data
- (2018) Ellen M. Lavoie Smith et al. CANCER NURSING
- Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy
- (2018) Daniel L. Hertz et al. CLINICAL CANCER RESEARCH
- COSMIN methodology for evaluating the content validity of patient-reported outcome measures: a Delphi study
- (2018) C. B. Terwee et al. QUALITY OF LIFE RESEARCH
- COSMIN guideline for systematic reviews of patient-reported outcome measures
- (2018) C. A. C. Prinsen et al. QUALITY OF LIFE RESEARCH
- In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials
- (2018) Ellen M. Lavoie Smith et al. Cancer Control
- Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- (2018) Maria Lee et al. Cancer Research and Treatment
- Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS)
- (2018) Loretta A. Williams et al. SUPPORTIVE CARE IN CANCER
- Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance for Clinical Trials in Oncology (Alliance) A151408 study data
- (2018) Ellen M. Lavoie Smith et al. SUPPORTIVE CARE IN CANCER
- The psychometric properties of the Turkish version of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool (CIPNAT)
- (2017) Sevinç Kutlutürkan et al. European Journal of Oncology Nursing
- Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20)
- (2017) Jacobien M. Kieffer et al. QUALITY OF LIFE RESEARCH
- COSMIN Risk of Bias checklist for systematic reviews of Patient-Reported Outcome Measures
- (2017) L. B. Mokkink et al. QUALITY OF LIFE RESEARCH
- Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy
- (2017) Robert Knoerl et al. SUPPORTIVE CARE IN CANCER
- Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey
- (2017) J . Matt McCrary et al. SUPPORTIVE CARE IN CANCER
- Validity of the Chemotherapy-induced Peripheral Neuropathy Self-Check Sheet
- (2015) Yumiko Miyoshi et al. INTERNAL MEDICINE
- Effect of duloxetine in Japanese patients with chemotherapy-induced peripheral neuropathy: a pilot randomized trial
- (2015) Yasuo Hirayama et al. International Journal of Clinical Oncology
- Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale
- (2015) Tito R. Mendoza et al. JOURNAL OF PAIN
- Reliability testing of oxaliplatin-associated neurotoxicity questionnaire (OANQ), a pilot study
- (2015) E. Gustafsson et al. SUPPORTIVE CARE IN CANCER
- Chemotherapy-induced neuropathy in multiple myeloma: influence on quality of life and development of a questionnaire to compose common toxicity criteria grading for use in daily clinical practice
- (2015) A. J. M. Beijers et al. SUPPORTIVE CARE IN CANCER
- Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
- (2015) Amylou C. Dueck et al. JAMA Oncology
- Reliability and Validity of the Korean Version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire to Assess Chemotherapy-induced Peripheral Neuropathy
- (2015) Hye Young Kim et al. Journal of Korean Academy of Nursing
- Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
- (2014) E. Basch et al. JNCI-Journal of the National Cancer Institute
- Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin
- (2013) P. Alberti et al. ANNALS OF ONCOLOGY
- Chemotherapy-induced peripheral neurotoxicity: A critical analysis
- (2013) Susanna B. Park et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)
- (2013) D. Binda et al. EUROPEAN JOURNAL OF CANCER
- Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)
- (2013) Charles L. Loprinzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing patient-reported peripheral neuropathy: the reliability and validity of the European Organization for Research and Treatment of Cancer QLQ-CIPN20 Questionnaire
- (2013) Ellen M. Lavoie Smith et al. QUALITY OF LIFE RESEARCH
- ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research
- (2013) Bryce B. Reeve et al. QUALITY OF LIFE RESEARCH
- The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
- (2012) G. Cavaletti et al. ANNALS OF ONCOLOGY
- Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy
- (2012) Brandi N. Reeves et al. CANCER
- The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA
- (2012) Sherry L. Wolf et al. SUPPORTIVE CARE IN CANCER
- Development and Psychometric Evaluation of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool
- (2011) Cindy S. Tofthagen et al. CANCER NURSING
- Precise evaluation of chemotherapy-induced peripheral neuropathy using the visual analogue scale: a quantitative and comparative analysis of neuropathy occurring with paclitaxel–carboplatin and docetaxel–carboplatin therapy
- (2011) Shuji Takemoto et al. International Journal of Clinical Oncology
- Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1
- (2011) Charles L. Loprinzi et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessing the impact of chemotherapy-induced peripheral neurotoxicity on the quality of life of cancer patients
- (2011) C. M. L. Driessen et al. SUPPORTIVE CARE IN CANCER
- Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties
- (2010) Kathleen A. Griffith et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA
- (2010) Debra L. Barton et al. SUPPORTIVE CARE IN CANCER
- Development of a methodological PubMed search filter for finding studies on measurement properties of measurement instruments
- (2009) Caroline B. Terwee et al. QUALITY OF LIFE RESEARCH
- Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02
- (2009) Kojiro Shimozuma et al. SUPPORTIVE CARE IN CANCER
- Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
- (2007) Dennis Revicki et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started